This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Soren Ljungberg Pedersen: Innovator in Pharmaceutical Science
Introduction
Soren Ljungberg Pedersen is a notable inventor based in Borup, Denmark. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative receptor agonists.
Latest Patents
Soren holds a patent for NPY2 receptor agonists. This invention relates to PYY analogues that feature alanine at position 4, lysine at position 7, QRY as the C-terminal end, and a half-life extending group. The analogues are designed to be soluble around pH 6 and 7. Additionally, the invention encompasses pharmaceutical compositions that include these PYY analogues and outlines their medical uses. He has 1 patent to his name.
Career Highlights
Soren is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work focuses on advancing therapeutic solutions that can improve patient outcomes.
Collaborations
Throughout his career, Soren has collaborated with esteemed colleagues such as Peter Wilhelm Haebel and Albert Brennauer. These partnerships have contributed to the success of his innovative projects.
Conclusion
Soren Ljungberg Pedersen exemplifies the spirit of innovation in the pharmaceutical industry. His work on PYY analogues showcases his commitment to advancing medical science and improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile